Y. Delmas

发表

MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.

J. Bulte, C. Moonen, C. Combe, 2006, Radiology.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Ultrasound-Induced Expression of a Heat Shock Promoter-Driven Transgene Delivered in the Kidney by Genetically Modified Mesenchymal Stem Cells: A Feasibility Study

C. Moonen, F. Moreau-Gaudry, R. Salomir, 2007 .

IgA nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review.

A. Amiot, A. Moktefi, N. Lapidus, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prognostic and Long-term Survival of Immune Thrombotic Thrombocytopenic Purpura in older patients.

K. Pérès, D. Chauveau, É. Azoulay, 2019, Blood.

Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

K. Pérès, D. Chauveau, É. Azoulay, 2019 .

Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure

É. Azoulay, F. Pène, G. Kaplanski, 2022, Research and practice in thrombosis and haemostasis.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura

D. Chauveau, J. Mira, É. Azoulay, 2015, Medicine.

Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.

C. Combe, J. Viallard, P. Blanco, 2005, Kidney international.

Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series

E. Thervet, P. Bruneval, J. Goujon, 2022, American Journal of Kidney Diseases.

New Developments in MRI in Assessment of Parenchymal Renal Diseases

C. Combe, N. Grenier, O. Hauger, 2006 .

Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.

O. Brissaud, J. Harambat, C. Contin-Bordes, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort

J. Harambat, Y. Delmas, A. Godron-Dubrasquet, 2018, Pediatric Nephrology.

USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans

C. Lasseur, C. Combe, N. Grenier, 2007, European Radiology.

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome

D. Chauveau, A. Servais, E. Rondeau, 2017, PloS one.

Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

G. Remuzzi, M. Noris, D. Kavanagh, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters.

M. Haissaguerre, F. Sacher, V. Rondeau, 2017, JACC. Clinical electrophysiology.

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

N. Jourde-Chiche, V. Frémeaux-Bacchi, A. Karras, 2018, Front. Immunol..

Mycophenolic acid antagonizes the activation of cultured human mesangial cells.

J. Bonnet, B. Vendrely, C. Combe, 2002, Kidney international.

Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome

A. Ryman, O. Brissaud, J. Harambat, 2011, Pediatric Nephrology.

Twice‐daily therapeutical plasma exchange‐based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

F. Pène, E. Maury, J. Thouret, 2016, European journal of haematology.

Plasma exchange Mechanical ventilation (neurological cause) Mechanical ventilation (other causes) Haemolytic uraemic syndrome Enteritis Eculizumab Immunoadsorption

C. Combe, H. Bui, G. Hilbert, 2012 .

Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center

P. Böelle, P. Boelle, J. Mira, 2015, Journal of thrombosis and haemostasis : JTH.

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

N. Sheerin, C. Licht, E. Rondeau, 2019, BMC Nephrology.

Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment

G. Ardissino, H. Haller, J. Walle, 2016, Journal of Nephrology.

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: A pediatric report and literature review

A. Ryman, O. Brissaud, J. Harambat, 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab

B. Vendrely, C. Combe, P. Rolland, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients

J. Moreau, N. Pelletier, T. Defrance, 2003, Immunology.

Verapamil and mild hyperkalemia in hemodialysis patients: A potentially hazardous association

E. Letavernier, L. Couzi, Y. Delmas, 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study

S. Tezenas du Montcel, F. Debellé, A. Testa, 2015, Blood Purification.

Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes

R. Prével, D. Gruson, E. Rivière, 2022, Journal of clinical medicine.

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

D. Chauveau, C. Deligny, L. Galicier, 2018, Blood.

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.

É. Azoulay, L. Galicier, M. Bubenheim, 2020, Blood.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre

D. Chauveau, É. Azoulay, L. Galicier, 2017, American journal of hematology.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

É. Azoulay, L. Galicier, E. Rondeau, 2016, The Lancet. Haematology.

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura.

É. Azoulay, L. Galicier, S. Bézieau, 2012, Blood.

Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.

L. Doucet, Y. Le Meur, V. Frémeaux-Bacchi, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases

J. Goujon, A. Servais, A. Karras, 2014 .

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

J. Goujon, A. Servais, F. Provôt, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw–Schulman Syndrome

J. Hogan, P. Coppo, F. Provôt, 2018, Thrombosis and Haemostasis.

Immunoadsorption in patients with haemolytic uraemic syndrome

C. Combe, H. Bui, G. Hilbert, 2012, The Lancet.

Eculizumab discontinuation in children and adults with atypical haemolytic uremic syndrome: a prospective multicentric study.

W. Hanf, C. Pouteil‐Noble, E. Rondeau, 2020, Blood.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

F. Petitprez, Z. Massy, C. Charasse, 2019, Journal of the American Society of Nephrology : JASN.

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

N. Sheerin, C. Licht, E. Rondeau, 2018, Clinical kidney journal.

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice

C. Combe, V. Frémeaux-Bacchi, C. Loirat, 2013, Clinical kidney journal.

Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count

A. Boyer, D. Gruson, A. Vital, 2015, Transfusion.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

G. Remuzzi, F. Eitner, C. Legendre, 2013, The New England journal of medicine.

Cytoskeletal Reorganization by Mycophenolic Acid Alters Mesangial Cell Migration and Contractility

J. Bonnet, C. Combe, Y. Delmas, 2003, Hypertension.

In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.

Nicolas Grenier, Zoran Ivanovic, Clemens Bos, 2004, Radiology.

Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys

B. Knebelman, N. Jourde-Chiche, Johan Noble, 2021, Kidney international reports.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome

K. Dahan, R. Salomon, O. Gribouval, 2018, Pediatric Nephrology.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

G. Remuzzi, C. Bedrosian, N. Sheerin, 2015, Kidney international.

High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy

D. Lacombe, C. Combe, R. Rossignol, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.

L. Alberio, G. Remuzzi, N. Winer, 2020, Blood.

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease

C. Combe, A. Ryman, P. Coppo, 2015, BMC Pregnancy and Childbirth.

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

J. Hogan, A. Servais, E. Rondeau, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

E. Daugas, A. Servais, S. Decramer, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

N. Heyne, Y. Miyakawa, G. Ariceta, 2021, Kidney international reports.

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.

N. Heyne, Y. Miyakawa, G. Ariceta, 2020, Kidney international.

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.

J. Peltier, G. Grateau, I. Jéru, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.

B. Knebelmann, C. Combe, F. Glowacki, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.

V. Vaillant, F. Terrier, F. Weill, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

N. Jourde-Chiche, J. Halimi, E. Rondeau, 2019, Kidney international.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

F. Petitprez, G. Choukroun, S. Burtey, 2017, Blood.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll‐like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

J. Mira, B. Guidet, É. Azoulay, 2013, Transfusion.

Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.

L. Salomon, A. Servais, C. Legendre, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats

M. Tanter, J. Gennisson, C. Combe, 2011, European Radiology.

Multiwave technology introducing shear wave elastography of the kidney: Pre-clinical study on a kidney fibrosis model and clinical feasibility study on 49 human renal transplants

Mickael Tanter, Jeremy Bercoff, Nicolas Grenier, 2010, 2010 IEEE International Ultrasonics Symposium.

Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review.

S. Olindo, I. Sibon, M. Poli, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

H. Chabriat, É. Azoulay, L. Galicier, 2023, Journal of Neurology.

Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.

S. Lepreux, C. Combe, J. Goujon, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017

F. Weill, E. Daugas, G. Choukroun, 2021, Emerging infectious diseases.